{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T15:49:21Z","timestamp":1767023361635,"version":"3.48.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,29]]},"DOI":"10.7759\/cureus.100342","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T15:47:12Z","timestamp":1767023232000},"source":"Crossref","is-referenced-by-count":0,"title":["Infantile Epsilon-Sarcoglycan (SGCE) Myoclonus-Dystonia: Diagnostic Pitfalls and Poor Response to Pharmacologic Treatment"],"prefix":"10.7759","author":[{"given":"Rita","family":"Pissarra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonor","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia","family":"Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.107216","article-title":"IAPRD new consensus classification of myoclonus","volume":"132","author":"Latorre A","year":"2025","unstructured":"Latorre A, van der Veen S, Pena A, et al.. IAPRD new consensus classification of myoclonus. Parkinsonism Relat Disord. 2025, 132:107216. 10.1016\/j.parkreldis.2024.107216","journal-title":"Parkinsonism Relat Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/epi4.12917","article-title":"Myoclonus: Differential diagnosis and current management","volume":"9","author":"Riva A","year":"2024","unstructured":"Riva A, D'Onofrio G, Ferlazzo E, et al.. Myoclonus: Differential diagnosis and current management. Epilepsia Open. 2024, 9:486-500. 10.1002\/epi4.12917","journal-title":"Epilepsia Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000001276","article-title":"Myoclonus: an update","volume":"37","author":"Thomas B","year":"2024","unstructured":"Thomas B, Frucht SJ. Myoclonus: an update. Curr Opin Neurol. 2024, 37:421-5. 10.1097\/WCO.0000000000001276","journal-title":"Curr Opin Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23088","article-title":"Definition and classification of hyperkinetic movements in childhood","volume":"25","author":"Sanger TD","year":"2010","unstructured":"Sanger TD, Chen D, Fehlings DL, et al.. Definition and classification of hyperkinetic movements in childhood. Mov Disord. 2010, 25:1538-49. 10.1002\/mds.23088","journal-title":"Mov Disord"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000577","article-title":"Myoclonus-dystonia: classification, phenomenology, pathogenesis, and treatment","volume":"31","author":"Roze E","year":"2018","unstructured":"Roze E, Lang AE, Vidailhet M. Myoclonus-dystonia: classification, phenomenology, pathogenesis, and treatment. Curr Opin Neurol. 2018, 31:484-90. 10.1097\/WCO.0000000000000577","journal-title":"Curr Opin Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000297516.98574.c0","article-title":"Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations","volume":"70","author":"Roze E","year":"2008","unstructured":"Roze E, Apartis E, Clot F, et al.. Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology. 2008, 70:1010-6. 10.1212\/01.wnl.0000297516.98574.c0","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27822","article-title":"Twenty years on: myoclonus-dystonia and \u03b5-sarcoglycan - neurodevelopment, channel, and signaling dysfunction","volume":"34","author":"Menozzi E","year":"2019","unstructured":"Menozzi E, Balint B, Latorre A, Valente EM, Rothwell JC, Bhatia KP. Twenty years on: myoclonus-dystonia and \u03b5-sarcoglycan - neurodevelopment, channel, and signaling dysfunction. Mov Disord. 2019, 34:1588-601. 10.1002\/mds.27822","journal-title":"Mov Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-021-02391-0","article-title":"\u03b5-Sarcoglycan: unraveling the myoclonus-dystonia gene","volume":"58","author":"Cazurro-Guti\u00e9rrez A","year":"2021","unstructured":"Cazurro-Guti\u00e9rrez A, Marc\u00e9-Grau A, Correa-Vela M, et al.. \u03b5-Sarcoglycan: unraveling the myoclonus-dystonia gene. Mol Neurobiol. 2021, 58:3938-52. 10.1007\/s12035-021-02391-0","journal-title":"Mol Neurobiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.15298","article-title":"Early recognition of SGCE-myoclonus-dystonia in children","volume":"65","author":"Correa-Vela M","year":"2023","unstructured":"Correa-Vela M, Carvalho J, Ferrero-Turrion J, et al.. Early recognition of SGCE-myoclonus-dystonia in children. Dev Med Child Neurol. 2023, 65:207-14. 10.1111\/dmcn.15298","journal-title":"Dev Med Child Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.16214","article-title":"Natural history of SGCE-associated myoclonus dystonia in children and adolescents","volume":"67","author":"De Francesch V","year":"2025","unstructured":"De Francesch V, Cazurro-Guti\u00e9rrez A, Timmers ER, et al.. Natural history of SGCE-associated myoclonus dystonia in children and adolescents. Dev Med Child Neurol. 2025, 67:740-9. 10.1111\/dmcn.16214","journal-title":"Dev Med Child Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00922-6","article-title":"Physiology-based treatment of myoclonus","volume":"17","author":"Pena AB","year":"2020","unstructured":"Pena AB, Caviness JN. Physiology-based treatment of myoclonus. Neurotherapeutics. 2020, 17:1665-80. 10.1007\/s13311-020-00922-6","journal-title":"Neurotherapeutics"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002631","article-title":"A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia","volume":"86","author":"Hainque E","year":"2016","unstructured":"Hainque E, Vidailhet M, Cozic N, et al.. A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia. Neurology. 2016, 86:1729-35. 10.1212\/WNL.0000000000002631","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25326","article-title":"Surgical treatment of myoclonus dystonia syndrome","volume":"28","author":"Rughani AI","year":"2013","unstructured":"Rughani AI, Lozano AM. Surgical treatment of myoclonus dystonia syndrome. Mov Disord. 2013, 28:282-7. 10.1002\/mds.25326","journal-title":"Mov Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2005.03.001","article-title":"Aggravation of epilepsy by antiepileptic drugs","volume":"33","author":"Sazgar M","year":"2005","unstructured":"Sazgar M, Bourgeois BF. Aggravation of epilepsy by antiepileptic drugs. Pediatr Neurol. 2005, 33:227-34. 10.1016\/j.pediatrneurol.2005.03.001","journal-title":"Pediatr Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.16241","article-title":"Developmental variability in paediatric SGCE-related myoclonus dystonia syndrome","volume":"67","author":"Tarrano C","year":"2025","unstructured":"Tarrano C, Worbe Y. Developmental variability in paediatric SGCE-related myoclonus dystonia syndrome. Dev Med Child Neurol. 2025, 67:695-6. 10.1111\/dmcn.16241","journal-title":"Dev Med Child Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/440211-infantile-epsilon-sarcoglycan-sgce-myoclonus-dystonia-diagnostic-pitfalls-and-poor-response-to-pharmacologic-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T15:47:13Z","timestamp":1767023233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/440211-infantile-epsilon-sarcoglycan-sgce-myoclonus-dystonia-diagnostic-pitfalls-and-poor-response-to-pharmacologic-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.100342","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,29]]}}}